Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $12,686 | 3 | 78.0% |
| Travel and Lodging | $1,643 | 7 | 10.1% |
| Food and Beverage | $1,460 | 22 | 9.0% |
| Education | $475.05 | 3 | 2.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Celgene Corporation | $8,243 | 7 | $0 (2017) |
| EMD Serono, Inc. | $7,061 | 12 | $0 (2021) |
| Genentech, Inc. | $336.86 | 5 | $0 (2018) |
| GENZYME CORPORATION | $231.86 | 2 | $0 (2020) |
| Biogen, Inc. | $132.35 | 2 | $0 (2018) |
| Genentech USA, Inc. | $122.06 | 1 | $0 (2017) |
| TG Therapeutics, Inc. | $52.13 | 2 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $36.48 | 2 | $0 (2017) |
| Horizon Therapeutics plc | $25.82 | 1 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $21.74 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $52.13 | 2 | TG Therapeutics, Inc. ($52.13) |
| 2021 | $478.70 | 3 | EMD Serono, Inc. ($452.88) |
| 2020 | $5,798 | 3 | EMD Serono, Inc. ($5,673) |
| 2019 | $935.14 | 8 | EMD Serono, Inc. ($935.14) |
| 2018 | $272.24 | 4 | Biogen, Inc. ($132.35) |
| 2017 | $8,727 | 15 | Celgene Corporation ($8,243) |
All Payment Transactions
35 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/06/2023 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $29.96 | General |
| Category: Immunology | ||||||
| 02/06/2023 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Education | In-kind items and services | $22.17 | General |
| Category: Immunology | ||||||
| 12/07/2021 | Horizon Therapeutics plc | UPLIZNA (Drug) | Food and Beverage | In-kind items and services | $25.82 | General |
| Category: UPLIZNA | ||||||
| 10/31/2021 | EMD Serono, Inc. | — | Education | In-kind items and services | $226.44 | General |
| 05/31/2021 | EMD Serono, Inc. | — | Education | In-kind items and services | $226.44 | General |
| 03/04/2020 | GENZYME CORPORATION | LEMTRADA (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Neurology | ||||||
| 01/23/2020 | EMD Serono, Inc. | Mavenclad (Drug) | Consulting Fee | Cash or cash equivalent | $5,625.00 | General |
| Category: Neurology | ||||||
| 01/23/2020 | EMD Serono, Inc. | Mavenclad (Drug) | Travel and Lodging | In-kind items and services | $48.17 | General |
| Category: Neurology | ||||||
| 12/06/2019 | EMD Serono, Inc. | Mavenclad (Biological) | Travel and Lodging | In-kind items and services | $284.00 | General |
| Category: Neurology | ||||||
| 12/06/2019 | EMD Serono, Inc. | Mavenclad (Biological) | Consulting Fee | In-kind items and services | $60.87 | General |
| Category: Neurology | ||||||
| 12/06/2019 | EMD Serono, Inc. | Mavenclad (Biological) | Food and Beverage | In-kind items and services | $49.98 | General |
| Category: Neurology | ||||||
| 12/06/2019 | EMD Serono, Inc. | Mavenclad (Biological) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: Neurology | ||||||
| 12/06/2019 | EMD Serono, Inc. | Mavenclad (Biological) | Food and Beverage | In-kind items and services | $34.99 | General |
| Category: Neurology | ||||||
| 12/05/2019 | EMD Serono, Inc. | Mavenclad (Biological) | Travel and Lodging | In-kind items and services | $240.25 | General |
| Category: Neurology | ||||||
| 12/05/2019 | EMD Serono, Inc. | Mavenclad (Biological) | Food and Beverage | In-kind items and services | $106.84 | General |
| Category: Neurology | ||||||
| 08/15/2019 | EMD Serono, Inc. | Mavenclad (Biological) | Food and Beverage | In-kind items and services | $123.21 | General |
| Category: Neurology | ||||||
| 12/13/2018 | GENZYME CORPORATION | LEMTRADA (Drug) | Food and Beverage | In-kind items and services | $106.86 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 07/31/2018 | Biogen, Inc. | — | Food and Beverage | Cash or cash equivalent | $119.75 | General |
| 04/02/2018 | Genentech, Inc. | OCREVUS (Biological) | Food and Beverage | In-kind items and services | $33.03 | General |
| Category: Immunology | ||||||
| 01/08/2018 | Biogen, Inc. | TECFIDERA (Drug) | Food and Beverage | In-kind items and services | $12.60 | General |
| Category: NEUROLOGY | ||||||
| 12/12/2017 | Genentech, Inc. | OCREVUS (Biological) | Food and Beverage | In-kind items and services | $98.95 | General |
| Category: Immunology | ||||||
| 12/02/2017 | Celgene Corporation | Ozanimod (Drug) | Consulting Fee | Cash or cash equivalent | $7,000.00 | General |
| 12/02/2017 | Celgene Corporation | Ozanimod (Drug) | Travel and Lodging | Cash or cash equivalent | $449.51 | General |
| 12/02/2017 | Celgene Corporation | — | Travel and Lodging | In-kind items and services | $202.36 | General |
| 12/02/2017 | Celgene Corporation | Ozanimod (Drug) | Food and Beverage | In-kind items and services | $150.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 16 | 25 | $9,375 | $1,895 |
| 2022 | 1 | 14 | 19 | $7,125 | $1,288 |
| 2021 | 1 | 17 | 24 | $9,000 | $1,913 |
| 2020 | 1 | 13 | 17 | $6,375 | $1,032 |
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 16 | 25 | $9,375 | $1,895 | 20.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 14 | 19 | $7,125 | $1,288 | 18.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 17 | 24 | $9,000 | $1,913 | 21.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 13 | 17 | $6,375 | $1,032 | 16.2% |
About Dr. David Pitt, MD
Dr. David Pitt, MD is a Neurology healthcare provider based in North Haven, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1790703221.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Pitt, MD has received a total of $16,264 in payments from pharmaceutical and medical device companies, with $52.13 received in 2023. These payments were reported across 35 transactions from 10 companies. The most common payment nature is "Consulting Fee" ($12,686).
As a Medicare-enrolled provider, Pitt has provided services to 60 Medicare beneficiaries, totaling 85 services with total Medicare billing of $6,128. Data is available for 4 years (2020–2023), covering 4 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location North Haven, CT
- Active Since 07/17/2006
- Last Updated 03/01/2021
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1790703221
Products in Payments
- Ozanimod (Drug) $7,824
- Mavenclad (Drug) $5,673
- Mavenclad (Biological) $935.14
- OCREVUS (Biological) $236.86
- Non-Covered Product (Drug) $222.06
- LEMTRADA (Biological) $125.00
- LEMTRADA (Drug) $106.86
- BRIUMVI (Drug) $52.13
- COPAXONE (Drug) $36.48
- UPLIZNA (Drug) $25.82
- GILENYA (Drug) $21.74
- TECFIDERA (Drug) $12.60
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in North Haven
Dr. Erin Longbrake, Md, MD
Neurology — Payments: $108,765
Katherine Destefano
Neurology — Payments: $10,126
Adeniyi Fisayo, M.d, M.D
Neurology — Payments: $4,014
Lori Cretella, Md, MD
Neurology — Payments: $1,034
Dr. John Peters, Md, MD
Neurology — Payments: $24.46